Karla Mankoff

Karla Mankoff serves as a key procurement lead within the Indian Health Service, specializing in the acquisition of advanced analytical laboratory instrumentation and diagnostic equipment critical to delivering culturally competent healthcare in tribal communities. Her role centers on executing contracts that align with the agency’s mission to modernize clinical diagnostics and reduce health disparities through targeted infrastructure investment. She manages the full lifecycle of acquisitions under the Buy Indian Set-Aside authority, ensuring compliance with federal statutes that prioritize American Indian and Alaska Native-owned businesses. Her portfolio primarily involves complex procurements for high-precision medical devices, laboratory analyzers, and associated calibration and maintenance services essential to tribal health clinics. Mankoff maintains enduring partnerships with a select group of contractors uniquely positioned to serve IHS mission needs, including McKesson Corporation for diagnostic supply chain logistics, Flintco, LLC for facility-integrated equipment installation, and tribal health entities such as Tribal Health, LLC and the Central Oklahoma American Indian Health Council, Inc. These relationships reflect a preference for vendors with demonstrated experience in rural, remote, and culturally sensitive healthcare environments. Her contracting approach emphasizes long-term vendor collaboration, technical alignment with tribal health protocols, and responsiveness to community-specific clinical requirements. She exclusively utilizes the Buy Indian Set-Aside program, directing 100% of eligible procurements to federally recognized Indian tribes, tribal organizations, and Alaska Native corporations. This unwavering commitment ensures socioeconomic benefits flow directly to Native-owned enterprises, reinforcing self-determination and capacity building within tribal health systems. Her contracting patterns reflect a deep integration of federal procurement regulations with tribal sovereignty principles, prioritizing indigenous ownership and operational autonomy. Her technical focus is narrowly centered on NAICS 334516—Analytical Laboratory Instrument Manufacturing—encompassing automated clinical analyzers, point-of-care diagnostic systems, and lab information management software. She specializes in procuring equipment that meets CLIA and CDC standards for infectious disease screening, chronic disease monitoring, and environmental health testing in underserved communities.